<PAGE>
_________________________________________________________________
_________________________________________________________________
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d)
of the Securities Exchange Act of 1934
November 6, 1997
Date of Report
(Date of Earliest Event Reported)
FCS LABORATORIES, INC.
(Exact name of Registrant as specified in its charter)
Commission File Number
0-13154
Arizona 95-2568559
(State of Incorporation) (I.R.S. Employer ID No.)
2330 So. Industrial Park Avenue, Tempe, Arizona 85282
(Address of principal executive offices) (Zip Code)
(602) 966-7248
(Registrant's telephone number, including area code)
_________________________________________________________________
_________________________________________________________________
<PAGE>
ITEM 5 - OTHER EVENTS
Mr. Gary A. Griffin has resigned as a member of the Board of
Directors. This resignation was effective November 6, 1997. Mr.
Griffin had served as a Director of the Company since July 1982.
At a meeting held telephonically on November 7, 1997, the Board
of Directors of the Company elected Salvatore V. Sigona to fill
the vacancy created by the resignation of Mr. Griffin.
Mr. Sigona, 59, joined the FCS Laboratories group of companies in
1989 as Director of Operations for Iatric Corporation and, since
that time, has held various positions. Currently, Mr. Sigona
serves as President and as a member of the Board of Directors of
the Company's five operating subsidiaries.
Signature
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, authorized officer.
Date: December 23, 1997 FCS LABORATORIES, INC.
/s/ Nicholas A. Gallo, III
__________________________
Nicholas A. Gallo, III
Chairman, member of the
Board of Directors
and President
<PAGE>
